Skip to main content
. 2020 Dec 27;12(12):1314–1325. doi: 10.4254/wjh.v12.i12.1314

Table 2.

Laboratory data in the beginning of the treatment

Laboratory data
Median (IQR)
Hemoglobin, g/dL 15.7 (14.9-16.0)
Leukocytes, × 109/L 7.9 (7.0-10.2)
Platelets, × 109/L 204.5 (175.8-238.8)
Albumin, g/dL 58.4 (55.0-61.1)
AST, U/L 36.0 (28.0-47.8)
ALT, U/L 47.0 (31.0-67.0)
GGT, U/L 41.5 (27.0-72.0)
Alkaline phosphatase, U/L 76.5 (65.5-94.5)
Total bilirubin, mg/dL 0.48 (0.32-0.6)
Total cholesterol, mg/dL 162.0 (142.0-200.0)
Alpha-fetoprotein, ng/mL 2.0 (1.4-3.5)
Creatinine, mg/dL 0.8 (0.7-0.9)
INR 1.0 (1.0-1.1)
Anti-HBc antibody+ 41 (41.8%)
Anti-HBs antibody+ 33 (33.7%)

ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: γ-glutamyl transpeptidase; IQR: Interquartile range.